Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED Trial.
Taylor P, Rajendram R, Hanna S, Wilson V, Pell J, Li C, Cook A, Gattamaneni R, Plowman N, Jackson S, Hills R, French R, Uddin JM, Lee RWJ, Dayan CM. Taylor P, et al. Among authors: dayan cm. J Clin Endocrinol Metab. 2023 Sep 18;108(10):2615-2625. doi: 10.1210/clinem/dgad084. J Clin Endocrinol Metab. 2023. PMID: 36971324 Free PMC article. Clinical Trial.
Genetic determinants of thyroid function in children.
Mulder TA, Campbell PJ, Taylor PN, Peeters RP, Wilson SG, Medici M, Dayan C, Jaddoe VVW, Walsh JP, Martin NG, Tiemeier H, Korevaar TIM. Mulder TA, et al. Among authors: dayan c. Eur J Endocrinol. 2023 Aug 2;189(2):164-174. doi: 10.1093/ejendo/lvad086. Eur J Endocrinol. 2023. PMID: 37530217 Free PMC article.
Liothyronine prescribing in England: costs versus need.
Heald A, Stedman M, Okosieme B, Premawardhana L, Taylor P, Dayan C. Heald A, et al. Among authors: dayan c. Lancet. 2023 Dec 2;402(10417):2074-2075. doi: 10.1016/S0140-6736(23)01792-0. Epub 2023 Nov 15. Lancet. 2023. PMID: 37979592 No abstract available.
Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design.
Premawardhana LD, Taylor PN, Okosieme OE, Adlan MA, Obuobie EK, Dayan CM. Premawardhana LD, et al. Front Endocrinol (Lausanne). 2023 Nov 16;14:1282608. doi: 10.3389/fendo.2023.1282608. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38034018 Free PMC article. Review.
293 results